Syncom Formulations P/E Ratio

SYNCOMF • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
15.48
Moderate Valuation
Moderate - Fairly valued

Current Valuation Metrics

P/E Ratio 15.48
Current Price ₹13.11
EPS (TTM) ₹0.57
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 37.39
Historical Range 21.69 - 44.4
Percentile 0.0%

Sector Context

Sector Average 47.72
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹0.78
Sept 2025 ₹0.18
Mar 2025 ₹0.16

Key P/E Ratio Insights for Syncom Formulations

  • Current PE is 58.6% below historical average
  • Trading at discount to sector average PE of 47.72

P/E Ratio Historical Trend for Syncom Formulations

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 21.69 0.78 ₹16.92 NSE Moderate
2024 39.22 0.51 ₹20.00 BSE High
2023 44.24 0.34 ₹15.04 BSE High
2022 44.4 0.2 ₹8.88 BSE High

Sector P/E Ratio Comparison

Comparing Syncom Formulations with other companies in Healthcare sector
Sector Average
47.72
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low